Metabolic regulation of TH17 cells

Mol Immunol. 2019 May:109:81-87. doi: 10.1016/j.molimm.2019.03.005. Epub 2019 Mar 20.

Abstract

IL-17-producing TH17 cells have been associated with autoimmune diseases such as multiple sclerosis (MS), psoriasis, Crohn's disease, and ulcerative colitis (Han et al., 2015), many of which lack effective therapies. Identifying effective approaches to selectively suppress TH17 cell development and function represents a legitimate strategy to cure these autoimmune disorders. TH17 cell differentiation requires rewiring of their metabolic program, transition from the oxidative phosphorylation-dominant catabolic phenotype in quiescent naïve T cells to glucose metabolism-orchestrated anabolic phenotype including lipogenesis. Here, we provide a focused review on the glycolytic-lipogenic pathway in TH17 development and pathogenicity. These studies reveal several metabolic checkpoints with specific regulation of TH17 cells (but not other T cell lineages), manifesting potential therapeutic opportunities to TH17 cell-mediated autoimmune diseases.

Keywords: Fatty acid synthesis; Glycolysis; HIF1α; T(H)17; mTOR.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Differentiation
  • Glycolysis
  • Humans
  • Lipogenesis
  • Signal Transduction
  • Th17 Cells / cytology
  • Th17 Cells / metabolism*